Get 20M+ Full-Text Papers For Less Than $1.50/day. Start a 14-Day Trial for You and Your Team.

Learn More →

Ranibizumab for Edema of the Macula in Diabetes Study

Ranibizumab for Edema of the Macula in Diabetes Study CLINICAL TRIALS SECTION EDITOR: ANNE S. LINDBLAD, PhD Ranibizumab for Edema of the Macula in Diabetes Study 3-Year Outcomes and the Need for Prolonged Frequent Treatment Diana V. Do, MD; Quan D. Nguyen, MD, MSc; Afsheen A. Khwaja, MD; Roomasa Channa, MD; Yasir J. Sepah, MBBS; Raafay Sophie, MD; Gulnar Hafiz, MD, MPH; Peter A. Campochiaro, MD; for the READ-2 Study Group Objective: To assess the benefit of increased follow-up number of ranibizumab injections was significantly greater and treatment with ranibizumab between months 24 and in the ranibizumab group compared with the laser group 36 in the Ranibizumab for Edema of the Macula in Dia- (5.4 vs 2.3 injections, P = .008) but not compared with betes (READ-2) Study. the ranibizumab laser group (3.3, P = .11). Design: Prospective, interventional, multicenter fol- Conclusions: More aggressive treatment with rani- low-up of a randomized clinical trial. bizumab during year 3 resulted in a reduction in mean FTH and improvement in BCVA in the ranibizumab Methods: Patients who agreed to participate between group. More extensive focal/grid laser therapy in the other months 24 and 36 (ranibizumab, 28 patients; laser, 22; 2 groups may have reduced the need for more frequent and ranibizumab http://www.deepdyve.com/assets/images/DeepDyve-Logo-lg.png JAMA Ophthalmology American Medical Association

Loading next page...
 
/lp/american-medical-association/ranibizumab-for-edema-of-the-macula-in-diabetes-study-hszB0tCZLq
Publisher
American Medical Association
Copyright
Copyright 2013 American Medical Association. All Rights Reserved. Applicable FARS/DFARS Restrictions Apply to Government Use.
ISSN
2168-6165
eISSN
2168-6173
DOI
10.1001/2013.jamaophthalmol.91
pmid
23544200
Publisher site
See Article on Publisher Site

Abstract

CLINICAL TRIALS SECTION EDITOR: ANNE S. LINDBLAD, PhD Ranibizumab for Edema of the Macula in Diabetes Study 3-Year Outcomes and the Need for Prolonged Frequent Treatment Diana V. Do, MD; Quan D. Nguyen, MD, MSc; Afsheen A. Khwaja, MD; Roomasa Channa, MD; Yasir J. Sepah, MBBS; Raafay Sophie, MD; Gulnar Hafiz, MD, MPH; Peter A. Campochiaro, MD; for the READ-2 Study Group Objective: To assess the benefit of increased follow-up number of ranibizumab injections was significantly greater and treatment with ranibizumab between months 24 and in the ranibizumab group compared with the laser group 36 in the Ranibizumab for Edema of the Macula in Dia- (5.4 vs 2.3 injections, P = .008) but not compared with betes (READ-2) Study. the ranibizumab laser group (3.3, P = .11). Design: Prospective, interventional, multicenter fol- Conclusions: More aggressive treatment with rani- low-up of a randomized clinical trial. bizumab during year 3 resulted in a reduction in mean FTH and improvement in BCVA in the ranibizumab Methods: Patients who agreed to participate between group. More extensive focal/grid laser therapy in the other months 24 and 36 (ranibizumab, 28 patients; laser, 22; 2 groups may have reduced the need for more frequent and ranibizumab

Journal

JAMA OphthalmologyAmerican Medical Association

Published: Feb 1, 2013

References

You’re reading a free preview. Subscribe to read the entire article.


DeepDyve is your
personal research library

It’s your single place to instantly
discover and read the research
that matters to you.

Enjoy affordable access to
over 18 million articles from more than
15,000 peer-reviewed journals.

All for just $49/month

Explore the DeepDyve Library

Search

Query the DeepDyve database, plus search all of PubMed and Google Scholar seamlessly

Organize

Save any article or search result from DeepDyve, PubMed, and Google Scholar... all in one place.

Access

Get unlimited, online access to over 18 million full-text articles from more than 15,000 scientific journals.

Your journals are on DeepDyve

Read from thousands of the leading scholarly journals from SpringerNature, Wiley-Blackwell, Oxford University Press and more.

All the latest content is available, no embargo periods.

See the journals in your area

DeepDyve

Freelancer

DeepDyve

Pro

Price

FREE

$49/month
$499/year

Save searches from
Google Scholar,
PubMed

Create folders to
organize your research

Export folders, citations

Read DeepDyve articles

Abstract access only

Unlimited access to over
18 million full-text articles

Print

20 pages / month